MediciNova, Inc..
MNOV.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
MediciNova, Inc. is a biopharmaceutical company focused on acquiring and developing novel, small-molecule therapeutics for the treatment of diseases with unmet medical needs. The company's pipeline includes products targeting neurological, inflammatory, and fibrotic diseases. MediciNova primarily fo...Show More
Better Health for All
0
No evidence available to assess MediciNova, Inc. on Better Health for All.
Fair Money & Economic Opportunity
0
No evidence available to assess MediciNova, Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
No evidence available to assess MediciNova, Inc. on Fair Pay & Worker Respect.
Fair Trade & Ethical Sourcing
0
No specific, concrete data points were found in the provided articles regarding MediciNova, Inc.'s performance on fair trade certifications, supplier audit frequency, forced or child labor incidents, supply chain traceability, remediation speed for violations, ethical clauses in supplier contracts, share of spend on high-risk materials, or procurement budget directed to diverse suppliers. While one article mentioned general supplier relationships and material availability as a risk factor for MediciNova,
1
and another detailed some operational aspects and a code of conduct for a partner company (Mitsubishi Tanabe Pharma Group),
2
none of this information provides direct, quantifiable evidence for MediciNova, Inc.'s ethical sourcing practices against the defined KPIs.
Honest & Fair Business
-50
MediciNova, Inc. has a Whistleblower Policy document, a Code of Business Conduct, and a Code of Ethics for Senior Officers.
1
However, in November 2010, the Board of Directors granted a waiver under the Code of Conduct to the President and CEO and another employee due to a possible conflict of interest related to joint real estate and banking transactions.
2
The company filed a 10-K/A on March 28, 2023, indicating an amendment to an annual report.
3
The company's Form 10-Q filing for September 30, 2024, includes certifications from the Principal Executive Officer and Principal Financial Officer regarding compliance with Securities Exchange Act Rules.
4
Kind to Animals
0
No evidence available to assess MediciNova, Inc. on Kind to Animals.
No War, No Weapons
0
MediciNova, Inc. is a biopharmaceutical company focused on developing therapeutics. The provided articles discuss stock market information, SEC filing dates, a clinical trial for Long COVID, and general EU export control regulations. One article mentions a conflict minerals sourcing policy, but explicitly states it does not contain data specific to MediciNova, Inc.
1
No information was found regarding the company's revenue from arms or defense contracts, investment in dual-use technologies, sales to embargoed regimes, peacebuilding initiatives, or any other metrics related to the 'No War, No Weapons' value.
Planet-Friendly Business
0
No evidence available to assess MediciNova, Inc. on Planet-Friendly Business.
Respect for Cultures & Communities
0
No evidence available to assess MediciNova, Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
0
No evidence available to assess MediciNova, Inc. on Safe & Smart Tech.
Zero Waste & Sustainable Products
0
No evidence available to assess MediciNova, Inc. on Zero Waste & Sustainable Products.